Signature Bioscience Inc is categorized under Research and Development Laboratories in San Francisco, CA and active since 2010.
Signature Bioscience Inc was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Mark Mcdade at the company’s single location by writing to 475 Brannan St # 300, San Francisco, California CA 94107 or by phoning (415) 490-2400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Signature Bioscience Inc |
Contact Person: | Mark Mcdade |
Address: | 475 Brannan St # 300, San Francisco, California 94107 |
Phone Number: | (415) 490-2400 |
Annual Revenue (USD): | $0 to $49.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Signature Bioscience Inc was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Mark Mcdade for inquiries that concern Signature Bioscience Inc by calling the company number (415) 490-2400, as your correspondence is most welcome. Additionally, the physical location of the single location of Signature Bioscience Inc can be found at the coordinates 37.778719,-122.395815 as well as the street address 475 Brannan St # 300 in San Francisco, California 94107.
For its online presence, you may visit Signature Bioscience Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.